# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-210627
Filing Date
2020-08-05
Accepted
2020-08-05 16:04:39
Documents
94
Period of Report
2020-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | d938521d10q.htm iXBRL | 10-Q | 3598873
2 | EX-18 | d938521dex18.htm | EX-18 | 3739
3 | EX-31.1 | d938521dex311.htm | EX-31.1 | 10335
4 | EX-31.2 | d938521dex312.htm | EX-31.2 | 10320
5 | EX-32 | d938521dex32.htm | EX-32 | 4308
| Complete submission text file | 0001193125-20-210627.txt |  | 13656661

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | teva-20200630.xsd | EX-101.SCH | 79100
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | teva-20200630_cal.xml | EX-101.CAL | 46326
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | teva-20200630_def.xml | EX-101.DEF | 522626
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | teva-20200630_lab.xml | EX-101.LAB | 534474
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | teva-20200630_pre.xml | EX-101.PRE | 562217
11 | EXTRACTED XBRL INSTANCE DOCUMENT | d938521d10q_htm.xml | XML | 3190712

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 201077200
SIC: 2834 Pharmaceutical Preparations